PEEPER; Daniel Simon
Patent Applications and Registrations
Patent applications and USPTO patent grants for PEEPER; Daniel Simon.The latest application filed is for "axl antibody-drug conjugates for use in treating cancer".
- PEEPER; Daniel Simon - Amstelveen NL
- PEEPER; Daniel Simon - Amsterdam NL
| Patent | Date |
|---|---|
| Axl Antibody-drug Conjugates For Use In Treating Cancer App 20220273809 - JANMAAT; Maarten ; et al. | 2022-09-01 |
| Method For Treating Cancer App 20220133721 - PEEPER; Daniel Simon ; et al. | 2022-05-05 |
| TWEAK-receptor agonists for use in combination with immunotherapy of a cancer App 20210269505 - Peeper; Daniel Simon ; et al. | 2021-09-02 |
| Axl-specific Antibody-drug Conjugates For Cancer Treatment App 20200397913 - BOSHUIZEN; Julia ; et al. | 2020-12-24 |
| ROCK in combination with MAPK pathway Grant 9,629,851 - Peeper , et al. April 25, 2 | 2017-04-25 |
| Method For Treating Cancer App 20170027940 - Peeper; Daniel Simon ; et al. | 2017-02-02 |
| ROCK in Combination with MAPK Pathway App 20160228451 - PEEPER; Daniel Simon ; et al. | 2016-08-11 |
| Fra-1 Target Genes As Drug Targets For Treating Cancer App 20120225076 - Peeper; Daniel Simon ; et al. | 2012-09-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 